Progesterone Agonist/Antagonist [EPC]

Known as: Mixed Progesterone Agonist and Antagonist, Progesterone Agonist/Antagonist, Selective Progesterone Receptor Modulator 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2018
01220052018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
STUDY QUESTION What is the impact of administration of the selective progesterone receptor modulator (SPRM), ulipristal acetate… (More)
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
2016
2016
STUDY QUESTION Does administration of vilaprisan (VPR) to healthy women for 12 weeks reduce menstrual bleeding? SUMMARY ANSWER… (More)
  • figure 1
  • figure 2
  • table I
  • figure 4
Is this relevant?
2016
2016
Use of estrogen or estrogen/progestin combination was an approved regimen for menopausal hormonal therapy (MHT). However, more… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2015
2015
OBJECTIVE To evaluate changes in proliferating and apoptotic markers of myoma tissue from patients treated with a selective… (More)
Is this relevant?
2015
2015
A woman in her late 40s presented with excessive per vagina (PV) bleeding and uterine fibroid. She reported excessive PV bleeding… (More)
Is this relevant?
2014
2014
OBJECTIVE Progesterone (P4) plays a central role in women's health. Synthetic progestins are used clinically in hormone… (More)
Is this relevant?
2014
2014
RESEARCH QUESTION What is the individualized bleeding experience of women with fibroids and anaemia in a 3 month randomized… (More)
Is this relevant?
2008
2008
The progesterone receptor plays an important role in the female reproductive system. Here we describe the discovery of a new… (More)
Is this relevant?
2006
2006
BACKGROUND This study was conducted to evaluate the effects of a novel selective progesterone receptor modulator (SPRM… (More)
Is this relevant?
2005
2005
BACKGROUND Asoprisnil (J867) is a novel selective progesterone receptor modulator (SPRM) that exhibits partial agonist and… (More)
Is this relevant?